Skip to main navigation
Decibel Therapeutics logo
Menu Button

Top Menu

  • JOIN US
  • CONTACT US

Main Corporate Nav

  • About Us
  • The Need
  • Our Approach
  • Pipeline
  • Patients & Families
    • Genetic Testing
    • Patients and Families
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Resources
      • Email Alerts
      • Investor Contact
      • Investor FAQs
  • Join Us
  • Contact Us

SEC Filings

Filing date Form Description View
March 17, 2023 4

Statement of changes in beneficial ownership of securities

0000899243-23-008873.pdf
0000899243-23-008873.rtf
0000899243-23-008873.xls
View HTML
March 14, 2023 10-K

Annual report which provides a comprehensive overview of the company for the past year

0000950170-23-007849.pdf
0000950170-23-007849.rtf
0000950170-23-007849.xls
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT View HTML
March 14, 2023 S-8

Securities offered to employees pursuant to employee benefit plans

0000950170-23-007881.pdf
0000950170-23-007881.rtf
0000950170-23-007881.xls
View HTML
March 13, 2023 8-K

Report of unscheduled material events or corporate event

0000950170-23-007382.pdf
0000950170-23-007382.rtf
0000950170-23-007382.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
February 14, 2023 SC 13G/A

An amendment to the SC 13G filing

0001104659-23-020734.pdf
0001104659-23-020734.rtf
View HTML
February 3, 2023 SC 13G

A statement of beneficial ownership of common stock by certain persons

0001306550-23-006964.pdf
0001306550-23-006964.rtf
View HTML
January 30, 2023 4

Statement of changes in beneficial ownership of securities

0000899243-23-002979.pdf
0000899243-23-002979.rtf
0000899243-23-002979.xls
View HTML
January 30, 2023 4

Statement of changes in beneficial ownership of securities

0000899243-23-002980.pdf
0000899243-23-002980.rtf
0000899243-23-002980.xls
View HTML
January 9, 2023 8-K

Report of unscheduled material events or corporate event

0001193125-23-004217.pdf
0001193125-23-004217.rtf
0001193125-23-004217.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 9, 2022 10-Q

Quarterly report which provides a continuing view of a company's financial position

0000950170-22-023819.pdf
0000950170-22-023819.rtf
0000950170-22-023819.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »
Displaying 1 - 10 of 127 results

Data provided by Kaleidoscope.

Shareholder Tools

Contact IR
Contact IR
Email Alerts
Email Alerts
Print Page
Print Page
RSS Feeds
RSS Feeds
Search
Search

© Decibel Therapeutics, Inc. 2023. All rights reserved.

  • Privacy Notice
  • Terms of Use
  • Twitter
  • LinkedIn

Main Corporate Nav

  • About Us
  • The Need
  • Our Approach
  • Pipeline
  • Patients & Families
    • Genetic Testing
    • Patients and Families
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Resources
      • Email Alerts
      • Investor Contact
      • Investor FAQs
  • Join Us
  • Contact Us